Eenmaal daags budesonide MMX bij actieve, milde tot matige colitis ulcerosa
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Auteurs: S. Travis et al.Tijdschrift: Gut. Maart 2014; 63(3): 433-41 Background Budesonide MMX is a novel oral formulation of budesonide that uses Multi-Matrix System (MMX) technology to extend release to the colon. This study compared the efficacy of budesonide MMX … Continued